117 related articles for article (PubMed ID: 1429919)
21. Pre-formulation and chemical stability studies of penethamate, a benzylpenicillin ester prodrug, in aqueous vehicles.
Jain R; Wu Z; Bork O; Tucker IG
Drug Dev Ind Pharm; 2012 Jan; 38(1):55-63. PubMed ID: 21696334
[TBL] [Abstract][Full Text] [Related]
22. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4.
Polonini H; da Silva SL; Brandão MAF; Bauters T; De Moerloose B; Ferreira AO
Int J Pharm Compd; 2018; 22(6):516-526. PubMed ID: 30384353
[TBL] [Abstract][Full Text] [Related]
23. Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate.
Lopalco A; Curci A; Lopedota A; Cutrignelli A; Laquintana V; Franco M; Denora N
Eur J Pharm Sci; 2019 Jan; 127():339-350. PubMed ID: 30447284
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA - loaded pellets developed for angina chronotherapy: Deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation.
Yan HX; Li J; Li ZH; Zhang WL; Liu JP
Eur J Pharm Sci; 2015 Aug; 76():156-64. PubMed ID: 25976225
[TBL] [Abstract][Full Text] [Related]
25. Miniaturized approach for excipient selection during the development of oral solid dosage form.
Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
[TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide.
Jacob S; Shirwaikar A; Nair A
Drug Dev Ind Pharm; 2009 Mar; 35(3):321-8. PubMed ID: 18821151
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
Limayem Blouza I; Charcosset C; Sfar S; Fessi H
Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
[TBL] [Abstract][Full Text] [Related]
28. Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children.
Trastullo R; Dolci LS; Passerini N; Albertini B
Int J Pharm; 2015 Nov; 495(1):536-550. PubMed ID: 26386139
[TBL] [Abstract][Full Text] [Related]
29. Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution.
Nagy ZK; Balogh A; Vajna B; Farkas A; Patyi G; Kramarics A; Marosi G
J Pharm Sci; 2012 Jan; 101(1):322-32. PubMed ID: 21918982
[TBL] [Abstract][Full Text] [Related]
30. Stability of pediatric liquid dosage forms of ethacrynic acid, indomethacin, methyldopate hydrochloride, prednisone and spironolactone.
Das Gupta V; Gibbs CW; Ghanekar AG
Am J Hosp Pharm; 1978 Nov; 35(11):1382-5. PubMed ID: 568384
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244).
Jonkman-de Vries JD; de Graaff-Teulen MJ; Henrar RE; Kettenes-van den Bosch JJ; Bult A; Beijnen JH
Invest New Drugs; 1994; 12(4):303-14. PubMed ID: 7775131
[TBL] [Abstract][Full Text] [Related]
32. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
Rajpoot P; Bali V; Pathak K
Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
[TBL] [Abstract][Full Text] [Related]
33. The Application of 3D Printing in the Formulation of Multilayered Fast Dissolving Oral Films.
Ehtezazi T; Algellay M; Islam Y; Roberts M; Dempster NM; Sarker SD
J Pharm Sci; 2018 Apr; 107(4):1076-1085. PubMed ID: 29208374
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation.
Dong Y; Ng WK; Shen S; Kim S; Tan RB
Int J Pharm; 2009 Jun; 375(1-2):84-8. PubMed ID: 19481693
[TBL] [Abstract][Full Text] [Related]
35. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
Zannou EA; Ji Q; Joshi YM; Serajuddin AT
Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
[TBL] [Abstract][Full Text] [Related]
36. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
[TBL] [Abstract][Full Text] [Related]
37. Effect of some formulation adjuncts on the stability of benzoyl peroxide.
Das Gupta V
J Pharm Sci; 1982 May; 71(5):585-7. PubMed ID: 7097508
[TBL] [Abstract][Full Text] [Related]
38. Preparation and Pharmacokinetics Evaluation of Solid Self-Microemulsifying Drug Delivery System (S-SMEDDS) of Osthole.
Sun C; Gui Y; Hu R; Chen J; Wang B; Guo Y; Lu W; Nie X; Shen Q; Gao S; Fang W
AAPS PharmSciTech; 2018 Jul; 19(5):2301-2310. PubMed ID: 29845504
[TBL] [Abstract][Full Text] [Related]
39. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT
J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying technique.
Yassin AE; Alanazi FK; El-Badry M; Alsarra IA; Barakat NS; Alanazi FK
Drug Dev Ind Pharm; 2009 Mar; 35(3):297-304. PubMed ID: 18821154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
